MedTrace Logo

A Study of MG1111 in Healthy Children

NCT03375502 · Status: COMPLETED · Phase: PHASE2/PHASE3 · Type: INTERVENTIONAL · Enrollment: 814

Last updated 2021-05-14

No results posted yet for this study

Summary

To assess the safety of MG1111 and to evaluate immunological non-inferiority of MG1111 versus comparator

Conditions

  • Healthy Children

Interventions

DRUG

Varicella Vaccine

The subject will receive investigational product or comparator.

Sponsors & Collaborators

  • Green Cross Corporation

    lead INDUSTRY

Study Design

Allocation
RANDOMIZED
Purpose
PREVENTION
Masking
QUADRUPLE
Model
PARALLEL

Eligibility

Min Age
12 Months
Max Age
12 Years
Sex
ALL
Healthy Volunteers
Yes

Timeline & Regulatory

Start
2016-11-26
Primary Completion
2019-01-29
Completion
2019-07-31

Countries

  • South Korea

Study Locations

More Related Trials

Read the full study record

This page highlights key information. For complete eligibility criteria, study locations, investigator contacts, and the full protocol, visit the original record on ClinicalTrials.gov.

View NCT03375502 on ClinicalTrials.gov